What is the share price of Titan Biotech Ltd (TITANBIO) today?
The share price of TITANBIO as on 27th June 2025 is ₹401.75. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Titan Biotech Ltd (TITANBIO) share?
The past returns of Titan Biotech Ltd (TITANBIO) share are- Past 1 week: 1.08%
- Past 1 month: -11.97%
- Past 3 months: -5.52%
- Past 6 months: -45.02%
- Past 1 year: -35.07%
- Past 3 years: 79.19%
- Past 5 years: 462.28%
What are the peers or stocks similar to Titan Biotech Ltd (TITANBIO)?
The peers or stocks similar to Titan Biotech Ltd (TITANBIO) include:What is the dividend yield % of Titan Biotech Ltd (TITANBIO) share?
The current dividend yield of Titan Biotech Ltd (TITANBIO) is 0.50.What is the market cap of Titan Biotech Ltd (TITANBIO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Titan Biotech Ltd (TITANBIO) is ₹331.99 Cr as of 27th June 2025.What is the 52 week high and low of Titan Biotech Ltd (TITANBIO) share?
The 52-week high of Titan Biotech Ltd (TITANBIO) is ₹1017.85 and the 52-week low is ₹373.65.What is the PE and PB ratio of Titan Biotech Ltd (TITANBIO) stock?
The P/E (price-to-earnings) ratio of Titan Biotech Ltd (TITANBIO) is 15.41. The P/B (price-to-book) ratio is 2.49.Which sector does Titan Biotech Ltd (TITANBIO) belong to?
Titan Biotech Ltd (TITANBIO) belongs to the Materials sector & Fertilizers & Agro Chemicals sub-sector.How to buy Titan Biotech Ltd (TITANBIO) shares?
You can directly buy Titan Biotech Ltd (TITANBIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Titan Biotech Ltd
TITANBIO Share Price
TITANBIO Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
TITANBIO Performance & Key Metrics
TITANBIO Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
15.43 | 2.49 | 0.50% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
28.03 | 3.54 | 1.57% |
TITANBIO Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
TITANBIO Company Profile
Titan Biotech Limited makes biological products. The Company offers its products under various categories, such as pharmaceuticals, nutraceuticals, food products, agro nutrients, biotechnology & fermentation, cosmetic ingredients etc.
TITANBIO Forecast
TITANBIO Forecasts
TITANBIO
TITANBIO
Income
Balance Sheet
Cash Flow
TITANBIO Income Statement
TITANBIO Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 53.02 | 57.82 | 65.60 | 80.50 | 143.03 | 124.49 | 145.94 | 165.82 | 160.36 | 160.37 | ||||||||||
Raw Materials | 35.80 | 30.58 | 36.55 | 40.25 | 69.98 | 61.64 | 74.61 | 85.33 | 131.02 | 131.03 | ||||||||||
Power & Fuel Cost | 2.09 | 3.19 | 3.25 | 3.59 | 4.19 | 6.67 | 8.98 | 10.24 | ||||||||||||
Employee Cost | 2.89 | 6.61 | 9.43 | 11.51 | 13.09 | 14.24 | 18.21 | 23.71 | ||||||||||||
Selling & Administrative Expenses | 3.87 | 7.85 | 9.40 | 8.40 | 6.47 | 6.31 | 9.21 | 10.75 | ||||||||||||
Operating & Other expenses | 2.72 | 2.16 | -2.63 | 2.20 | 2.65 | 3.43 | 3.48 | -0.25 | ||||||||||||
EBITDA | 5.65 | 7.43 | 9.60 | 14.55 | 46.65 | 32.20 | 31.45 | 36.04 | 29.34 | 29.34 | ||||||||||
Depreciation/Amortization | 0.82 | 0.93 | 1.71 | 1.80 | 2.22 | 2.37 | 2.60 | 3.33 | 4.17 | 4.17 | ||||||||||
PBIT | 4.83 | 6.50 | 7.89 | 12.75 | 44.43 | 29.83 | 28.85 | 32.71 | 25.17 | 25.17 | ||||||||||
Interest & Other Items | 1.48 | 2.39 | 2.34 | 2.35 | 1.73 | 0.87 | 0.75 | 1.17 | 0.80 | 0.81 | ||||||||||
PBT | 3.35 | 4.11 | 5.55 | 10.40 | 42.70 | 28.96 | 28.10 | 31.54 | 24.37 | 24.36 | ||||||||||
Taxes & Other Items | 1.17 | 1.56 | 2.03 | 3.34 | 12.37 | 7.28 | 3.27 | 6.68 | 2.83 | 2.85 | ||||||||||
Net Income | 2.18 | 2.55 | 3.52 | 7.06 | 30.33 | 21.68 | 24.83 | 24.86 | 21.54 | 21.51 | ||||||||||
EPS | 2.82 | 3.30 | 4.40 | 8.54 | 36.70 | 26.24 | 30.05 | 30.08 | 26.06 | 26.03 | ||||||||||
DPS | 0.75 | 0.75 | 0.00 | 1.00 | 1.50 | 1.50 | 1.80 | 2.00 | 2.00 | 2.00 | ||||||||||
Payout ratio | 0.27 | 0.23 | 0.00 | 0.12 | 0.04 | 0.06 | 0.06 | 0.07 | 0.08 | 0.08 |
TITANBIO Company Updates
TITANBIO Stock Peers
TITANBIO Past Performance & Peer Comparison
TITANBIO Past Performance & Peer Comparison
MaterialsFertilizers & Agro Chemicals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Titan Biotech Ltd | 15.41 | 2.49 | 0.50% |
Coromandel International Ltd | 34.70 | 7.59 | 0.62% |
Fertilisers And Chemicals Travancore Ltd | 1,523.59 | 45.66 | 0.02% |
UPL Ltd | 64.97 | 1.78 | 0.81% |
TITANBIO Stock Price Comparison
Compare TITANBIO with any stock or ETFTITANBIO Holdings
TITANBIO Shareholdings
TITANBIO Promoter Holdings Trend
TITANBIO Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
TITANBIO Institutional Holdings Trend
TITANBIO Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
TITANBIO Shareholding Pattern
TITANBIO Shareholding Pattern
TITANBIO Shareholding History
TITANBIO Shareholding History
smallcases containing TITANBIO stock
smallcases containing TITANBIO stock
Looks like this stock is not in any smallcase yet.
TITANBIO Events
TITANBIO Events
TITANBIO Dividend Trend
TITANBIO has increased or maintained dividend levels over the last 5 years
Current dividend yield is 0.50%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹4.98 every year
Dividends
Corp. Actions
Announcements
Legal Orders
TITANBIO Dividend Trend
TITANBIO has increased or maintained dividend levels over the last 5 years
Current dividend yield is 0.50%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹4.98 every year
TITANBIO Upcoming Dividends
TITANBIO Upcoming Dividends
No upcoming dividends are available
TITANBIO Past Dividends
TITANBIO Past Dividends
Cash Dividend
Ex DateEx DateSep 23, 2024
Dividend/Share
₹2.00
Ex DateEx Date
Sep 23, 2024
Cash Dividend
Ex DateEx DateSep 22, 2023
Dividend/Share
₹1.80
Ex DateEx Date
Sep 22, 2023
Cash Dividend
Ex DateEx DateSep 22, 2022
Dividend/Share
₹1.50
Ex DateEx Date
Sep 22, 2022
Cash Dividend
Ex DateEx DateSep 16, 2021
Dividend/Share
₹1.50
Ex DateEx Date
Sep 16, 2021
Cash Dividend
Ex DateEx DateSep 17, 2020
Dividend/Share
₹1.00
Ex DateEx Date
Sep 17, 2020
TITANBIO Stock News & Opinions
TITANBIO Stock News & Opinions
Net profit of Titan Biotech declined 19.00% to Rs 4.05 crore in the quarter ended March 2025 as against Rs 5.00 crore during the previous quarter ended March 2024. Sales declined 11.90% to Rs 35.17 crore in the quarter ended March 2025 as against Rs 39.92 crore during the previous quarter ended March 2024. For the full year,net profit declined 13.36% to Rs 21.53 crore in the year ended March 2025 as against Rs 24.85 crore during the previous year ended March 2024. Sales declined 4.64% to Rs 156.45 crore in the year ended March 2025 as against Rs 164.07 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales35.1739.92 -12 156.45164.07 -5 OPM %12.9917.74 -16.2520.89 - PBDT5.877.21 -19 28.5434.86 -18 PBT5.036.37 -21 24.3731.53 -23 NP4.055.00 -19 21.5324.85 -13 Powered by Capital Market - Live
Titan Biotech announced that the Board of Directors of the Company at its meeting held on 30 May 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 20%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Titan Biotech will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
Net profit of Titan Biotech declined 38.77% to Rs 4.39 crore in the quarter ended December 2024 as against Rs 7.17 crore during the previous quarter ended December 2023. Sales declined 16.75% to Rs 38.28 crore in the quarter ended December 2024 as against Rs 45.98 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales38.2845.98 -17 OPM %12.6723.05 - PBDT6.2910.78 -42 PBT5.109.94 -49 NP4.397.17 -39 Powered by Capital Market - Live
Titan Biotech will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
Net profit of Titan Biotech rose 2.76% to Rs 6.70 crore in the quarter ended September 2024 as against Rs 6.52 crore during the previous quarter ended September 2023. Sales declined 8.15% to Rs 39.89 crore in the quarter ended September 2024 as against Rs 43.43 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales39.8943.43 -8 OPM %19.4520.08 - PBDT7.818.99 -13 PBT6.728.13 -17 NP6.706.52 3 Powered by Capital Market - Live
Titan Biotech will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
Titan Biotech announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Net profit of Titan Biotech rose 3.90% to Rs 6.40 crore in the quarter ended June 2024 as against Rs 6.16 crore during the previous quarter ended June 2023. Sales rose 24.06% to Rs 43.11 crore in the quarter ended June 2024 as against Rs 34.75 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales43.1134.75 24 OPM %19.1422.71 - PBDT8.567.88 9 PBT7.527.09 6 NP6.406.16 4 Powered by Capital Market - Live
Titan Biotech will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 20.38%, vs industry avg of 10.4%
Over the last 5 years, market share increased from 0.05% to 0.08%
Over the last 5 years, net income has grown at a yearly rate of 47.84%, vs industry avg of -4.05%